Clinical Trials Search at Vanderbilt-Ingram Cancer Center
A Study of ALX148 With Azacitidine for Higher Risk Myelodysplastic Syndrome (ASPEN-02)
Myelodysplastic Syndrome
Myelodysplastic Syndrome
This Phase 1 / 2 clinical study will evaluate ALX148 in combination with azacitidine for the treatment of patients with higher risk myelodysplastic syndrome (MDS).
Myelodysplastic Syndrome
I/II
Byrne, Michael
NCT04417517
VICCHEMP2084
